Among all the inaccurate things that are stated ab
Post# of 72440
Posted On: 10/24/2015 6:12:10 PM
Among all the inaccurate things that are stated about Cellceutix the top 2 seem to be time line and credibility. Both can be squashed with good DD. As the company moves forward, especially in such a position of success, there will be many that try to mince every word that is written and or said.
Facts -
The company never gave any time line to up-list except one time in an interview saying the plan was for this year (2015) The rumblings that this has lead investors wrong is very inaccurate! As good as Cellceutix has been at keeping investors updated(I for one have appreciated), has also keep the wolves close by the door. Giving them the opportunity to smash down every bit of news that is released and turn it in to a non event, as seen in the false SA article. So they will keep carrying that torch and may proclaim that partner or up-list is the only way to save the company.The company doesn't require a high SP to conduct and continue through trials this has been discussed ad nausseam! They only thing the attacks on the company have done was drop SP it hasn't slowed anything else down! Well maybe partner discussions, but I don't even think that matters as Cellceutix stands in a position to negotiate anyway.
I would also like to state that Cellceutix has been working very hard to do the up-list so they are reporting and filing at the level required to be on NASDAQ, they aren't trying to con anybody.
When your doing your DD find it in print. You will be told things like Phase 2 is meaningless phase 3 is the answer, the same thing was said about phase 1 to phase 2. Phase 3 is a given now and just waiting for the "real" time it takes to set up a trial. But if you look at the phase 2 results you will see phase 3 has been very de-risked by the quality of the results. Kevetrin is the same thing phase one took longer than expected(welcome the world of medicine development). But the quality of the results are outstanding, by a hospital that is equally outstanding!
Cellceutix isn't a guaranteed success by no means. But if you take a look at where it is, I would much rather be putting my money in a bio with 5 trials, 3 major drugs and phase 2s going on and completed and a phase 3 about to start, over a bio with one drug. Do the math look around compare values of companies.
When you get to money "issue" they have a lot of funding on hand, should they need it. Take a good look at how much the company is burning through! They are using a lot of grants and some trials they are just supplying the drugs.
Remember it is the internet where names have been change to protect... everybody... so consider the source of the information you receive. Then make a real assessment of the company if you are really considering investing in the company on the long side!
Know What you own
Facts -
The company never gave any time line to up-list except one time in an interview saying the plan was for this year (2015) The rumblings that this has lead investors wrong is very inaccurate! As good as Cellceutix has been at keeping investors updated(I for one have appreciated), has also keep the wolves close by the door. Giving them the opportunity to smash down every bit of news that is released and turn it in to a non event, as seen in the false SA article. So they will keep carrying that torch and may proclaim that partner or up-list is the only way to save the company.The company doesn't require a high SP to conduct and continue through trials this has been discussed ad nausseam! They only thing the attacks on the company have done was drop SP it hasn't slowed anything else down! Well maybe partner discussions, but I don't even think that matters as Cellceutix stands in a position to negotiate anyway.
I would also like to state that Cellceutix has been working very hard to do the up-list so they are reporting and filing at the level required to be on NASDAQ, they aren't trying to con anybody.
When your doing your DD find it in print. You will be told things like Phase 2 is meaningless phase 3 is the answer, the same thing was said about phase 1 to phase 2. Phase 3 is a given now and just waiting for the "real" time it takes to set up a trial. But if you look at the phase 2 results you will see phase 3 has been very de-risked by the quality of the results. Kevetrin is the same thing phase one took longer than expected(welcome the world of medicine development). But the quality of the results are outstanding, by a hospital that is equally outstanding!
Cellceutix isn't a guaranteed success by no means. But if you take a look at where it is, I would much rather be putting my money in a bio with 5 trials, 3 major drugs and phase 2s going on and completed and a phase 3 about to start, over a bio with one drug. Do the math look around compare values of companies.
When you get to money "issue" they have a lot of funding on hand, should they need it. Take a good look at how much the company is burning through! They are using a lot of grants and some trials they are just supplying the drugs.
Remember it is the internet where names have been change to protect... everybody... so consider the source of the information you receive. Then make a real assessment of the company if you are really considering investing in the company on the long side!
Know What you own
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Keep in mind that message boards require you to agree to thier manipulation or you are a lying basher! Also remember those that accuse are often riddle with quilt of performing the same which they accuse.
Scroll down for more posts ▼